GSK_Annual_Report_2021

Statutory Reports GlaxoSmithKline Pharmaceuticals Limited 56 Biosimilars. He held the role of General Manager, Singapore before taking up the role of Commercial Head, India, from 2014 to 2016. He was then appointed as Vice President of Central America & Caribbean before taking on the current role of Vice President, Emerging Markets East, managing direct oversight of six markets (Philippines, Vietnam, Thailand, Malaysia, Indonesia and Sri Lanka). Sridhar started his career with Eli Lilly and Company and then moved to Pfizer, holding increasingly senior roles including the role of Senior Director, Business Development (Asia) for Pfizer before joining GSK. Mr. Sridhar is a Registered Pharmacist, with a Master’s in Pharmacy (Pharmaceutical Marketing). He is a member of the Stakeholders Relationship Committee and the Corporate Social Responsibility Committee. He is a Director in Biddle Sawyer Limited. Dr. (Ms.) Sunita Maheshwari - Independent Director (Din : 01641411) Dr. (Ms.) Sunita Maheshwari, Outlook Business WOW 2019 (Woman of Worth) and 2014’s ‘Amazing Indian’ award by Times Now, is a US Board certified Pediatric Cardiologist who did her MBBS at Osmania Medical College followed by postgraduation at AIIMS, Delhi and Yale University in the US. She was the winner of the ‘Young Clinician Award’ from the American Heart Association and the ‘Best Teacher Award’ at Yale University. She was nominated one of the Top 20 women achievers in medicine in India in 2009 and in the list of 50 most powerful women in India in 2016. Apart from her medical clinical work, she is a medical entrepreneur and cofounded and is the Chief Dreamer at Teleradiology Solutions (India’s first and largest teleradiology company that has provided over 5 million diagnostic reports to patients and hospitals globally), Telrad Tech which builds AI enabled tele-health software, RXDX Healthcare-multi-specialty neighbourhood clinics in Bangalore, and has incubated other start-up companies in the tele-health space such as Healtheminds - a tele-counselling platform. She is active in the social arena in India where she runs 2 trust funds. People4people has put up over 500 playgrounds in government schools and Telerad Foundation provides teleradiology and telemedicine services to poor areas in Asia that do not have access to high quality medical care. Her expertise is in the field of Medical Science. She is the member of the Corporate Social Responsibility Committee. Mark Dawson – Non-Executive Director (Din : 09032378) Mark Dawson, age 50 years, is Vice President of Manufacturing and Supply Chain for Primary and Established Products (PEP) within GSK’s Pharmaceutical Business. He is responsible for the Supply Chain that manufactures all GSK Primary (API) products, Antibiotics supply chain and Regional Rx manufacturing with 18 facilities located across Europe, LatAm, MEA, India, China, Singapore and Australia. He is also responsible for all supply chain planning, logistics and warehousing operations into 105 global markets from LatAm, Middle East, Africa, Russia/ CIS, India, Pakistan, China and South Asia. He is a member of the Pharma Supply Chain Executive Team and the Emerging Markets Leadership Team. He is a member of GSK’s Global Gender Diversity Council. He joined GSK in 2005 working in various roles of increasing seniority within Global Manufacturing and Supply as Engineering Director, Site Director for the Irvine manufacturing site, Vice President and Head of Global Supply Chain within ViiV Healthcare (GSK’s HIV business) and latterly as Vice President and Head of Supply Chain for Emerging Markets. Prior to GSK, he has worked for several multinational companies including Eli Lilly and Company, Kvaerner and Schneider Electric. He is a graduate of the University of Sheffield in the UK and a Chartered Engineer. He has expertise in the field of Supply Chain. He does not hold any shares in the Company and is also not related to any Director of the Company.  Independent Directors have confirmed that they meet the criteria of independence as laid down under the Companies Act and the SEBI Listing Regulations as amended.  Company has obtained certificate from Practicing Company Secretaries, Parikh & Associates confirming that none of the Directors on Board is debarred or disqualified from being appointed or continuing as Directors of the Companies by the Board/Ministry of Corporate Affairs or any such statutory authority.